z-logo
open-access-imgOpen Access
Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor.
Author(s) -
Masanori Hatakeyama,
Seijiro Minamoto,
Tadatsugu Taniguchi
Publication year - 1986
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.83.24.9650
Subject(s) - phosphorylation , interleukin 13 receptor , receptor , 5 ht5a receptor , biology , enzyme linked receptor , interleukin 21 receptor , signal transduction , microbiology and biotechnology , protease activated receptor 2 , interleukin 4 receptor , serine , biochemistry , phosphorylation cascade , protein phosphorylation , protein kinase a , insulin like growth factor 1 receptor , growth factor
Tac antigen, the receptor for human interleukin 2 (IL-2), contains in its intracytoplasmic region a serine residue (Ser-247) that is seemingly the predominant site of protein kinase C-mediated phosphorylation. A number of studies on growth factor receptors have suggested the importance of phosphorylation in receptor structure, function, and regulation. In this study, we generated site-directed mutations in the Tac antigen cDNA to generate mutant receptors in which Ser-247 or Thr-250, a probable site of minor phosphorylation, was replaced with another amino acid that is not accessible to phosphorylation. Study of the expression of these mutant genes in a T-lymphoid cell line has provided no evidence as to the essential role of the above-mentioned residues in determining the degree of receptor affinity, its ability for signal transduction, and phorbol ester-mediated regulation of the receptor. Our results strongly suggest the existence of an IL-2 receptor "complex" in which the Tac antigen is associated with another molecule(s) that is involved in receptor structure, function, and regulation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here